- First and Only, Integrated In-Procedure Confirmation for Ablation of Soft Tissue Lesions -
MADISON, WI. / MINNEAPOLIS, MN., – JULY 30, 2015 - NeuWave Medical® Inc., a privately held medical device company focused on developing disruptive technology for use in the ablation of soft-tissue lesions has received FDA clearance for its new Ablation Confirmation™ (AC) software integrated into the NeuWave Intelligent Ablation System. The totality of the NeuWave System now with AC gives physicians the first, and only, in-procedure confirmation of ablation.
Ablation Confirmation™ (AC), is a Computed Tomography (CT) image processing software package that assists physicians in identifying ablation targets, assessing proper ablation probe placement and confirming ablation zones post-procedure. AC imports images from CT scanners and facility PACS systems for display and processing during ablation procedures and is accessible to physicians via a dedicated monitor with its own user interface on the NeuWave Intelligent Ablation System. The clearance of AC marks the first and only, integrated in-procedure ablation confirmation software available on an ablation system.